<p>The UK medical regulator said Saturday that out of 30 people who suffered blood clots after receiving the Oxford-AstraZeneca vaccine, seven have died.</p>.<p>The British acknowledgement of deaths comes as several European countries have paused the use of the AstraZeneca jab over a potential link to blood clots.</p>.<p>The UK's Medicines and Healthcare products Regulatory Agency said in a statement that "out of the 30 reports up to and including 24 March, sadly 7 have died."</p>.<p><strong>Read: <a href="https://www.deccanherald.com/international/world-news-politics/uk-regulator-found-total-of-30-cases-of-blood-clot-events-after-astrazeneca-covid-19-vaccine-use-969300.html" target="_blank">UK regulator found total of 30 cases of blood clot events after AstraZeneca Covid-19 vaccine use </a></strong></p>.<p>The Netherlands on Friday halted vaccinations with the AstraZeneca jab for people under the age of 60 after five new cases among women, one of whom died.</p>.<p>Germany took a similar decision earlier this week.</p>.<p>The European Medicines Agency (EMA), which like the World Health Organization previously declared the AstraZeneca vaccine safe, is expected to announce updated advice on the issue on April 7.</p>.<p>The EMA said again on Wednesday it believes the vaccine is safe and that experts have found no specific risk factors such as age, gender or medical history.</p>.<p>The UK regulator said that the 30 reports of thrombosis, submitted by medics or members of the public via a government website, came after 18.1 million doses of the vaccine had been administered in the country.</p>.<p><strong>Read more: <a href="https://www.deccanherald.com/international/what-we-know-about-astrazeneca-blood-clot-reports-968825.html" target="_blank">What we know about AstraZeneca blood clot reports </a></strong></p>.<p>Most of the cases (22) were cerebral venous sinus thrombosis, a rare condition when a blood clot forms in the brain.</p>.<p>Eight other cases saw people suffer thrombosis and low levels of blood platelets, which help blood clot.</p>.<p>There were no reports of blood clots from the Pfizer/BioNTech vaccine it said, adding that "our thorough review into these reports is ongoing."</p>.<p>The regulator's website says that on the basis of current data, the benefits of the vaccines against Covid-19 "continue to outweigh any risks".</p>.<p>AstraZeneca said last month following US efficiency trials that its vaccine is 79 per cent effective at preventing the disease and does not increase the risk of blood clots.</p>.<p>The UK has administered more than 31 million first vaccine doses, using both the Oxford-AstraZeneca and the Pfizer-BioNTech jabs. People cannot choose which one they get.</p>.<p>The UK in June 2020 ordered 100 million doses of the Oxford-AstraZeneca vaccine and supported its development. It also ordered 30 million doses of the Pfizer-BioNTech vaccine the same year.</p>
<p>The UK medical regulator said Saturday that out of 30 people who suffered blood clots after receiving the Oxford-AstraZeneca vaccine, seven have died.</p>.<p>The British acknowledgement of deaths comes as several European countries have paused the use of the AstraZeneca jab over a potential link to blood clots.</p>.<p>The UK's Medicines and Healthcare products Regulatory Agency said in a statement that "out of the 30 reports up to and including 24 March, sadly 7 have died."</p>.<p><strong>Read: <a href="https://www.deccanherald.com/international/world-news-politics/uk-regulator-found-total-of-30-cases-of-blood-clot-events-after-astrazeneca-covid-19-vaccine-use-969300.html" target="_blank">UK regulator found total of 30 cases of blood clot events after AstraZeneca Covid-19 vaccine use </a></strong></p>.<p>The Netherlands on Friday halted vaccinations with the AstraZeneca jab for people under the age of 60 after five new cases among women, one of whom died.</p>.<p>Germany took a similar decision earlier this week.</p>.<p>The European Medicines Agency (EMA), which like the World Health Organization previously declared the AstraZeneca vaccine safe, is expected to announce updated advice on the issue on April 7.</p>.<p>The EMA said again on Wednesday it believes the vaccine is safe and that experts have found no specific risk factors such as age, gender or medical history.</p>.<p>The UK regulator said that the 30 reports of thrombosis, submitted by medics or members of the public via a government website, came after 18.1 million doses of the vaccine had been administered in the country.</p>.<p><strong>Read more: <a href="https://www.deccanherald.com/international/what-we-know-about-astrazeneca-blood-clot-reports-968825.html" target="_blank">What we know about AstraZeneca blood clot reports </a></strong></p>.<p>Most of the cases (22) were cerebral venous sinus thrombosis, a rare condition when a blood clot forms in the brain.</p>.<p>Eight other cases saw people suffer thrombosis and low levels of blood platelets, which help blood clot.</p>.<p>There were no reports of blood clots from the Pfizer/BioNTech vaccine it said, adding that "our thorough review into these reports is ongoing."</p>.<p>The regulator's website says that on the basis of current data, the benefits of the vaccines against Covid-19 "continue to outweigh any risks".</p>.<p>AstraZeneca said last month following US efficiency trials that its vaccine is 79 per cent effective at preventing the disease and does not increase the risk of blood clots.</p>.<p>The UK has administered more than 31 million first vaccine doses, using both the Oxford-AstraZeneca and the Pfizer-BioNTech jabs. People cannot choose which one they get.</p>.<p>The UK in June 2020 ordered 100 million doses of the Oxford-AstraZeneca vaccine and supported its development. It also ordered 30 million doses of the Pfizer-BioNTech vaccine the same year.</p>